Skip to main content

Table 3 Hazard ratios (HRs) and 95% confidence intervals (CIs) of urological cancer among sampled subjects during the 5-year follow-up period from the index date according to the type of urological cancer

From: Increased risk for urological cancer associated with anxiety disorder: a retrospective cohort study

Presence of urological cancer

Patients with anxiety disorder n = 58,603

Comparison cohort n = 58,603

No.

Percent

No.

Percent

Kidney cancer

 Yes

67 (0.11)

21 (0.04)

 Incidence rate per 100,000 person-years (95% CI)

23.20 (17.98 ~ 29.47)

7.24 (4.48 ~ 11.07)

 Adjusted HRa,b (95% CI)

2.84*** (1.73 ~ 4.66)

1.00

Bladder cancer

 Yes

88 (0.15)

26 (0.04)

 Incidence rate per 100,000 person-years (95% CI)

30.48 (24.45 ~ 37.55)

8.97 (5.86 ~ 13.14)

 Adjusted HRa,b (95% CI)

2.94*** (1.89 ~ 4.58)

1.00

Prostate cancer (men only)

 Yes

138 (0.62)

26 (0.12)

 Incidence rate per 10,000 person-years (95% CI)

12.53 (10.53 ~ 14.81)

2.35 (1.53 ~ 3.44)

 Adjusted HRa,b (95% CI)

4.67*** (3.06 ~ 7.12)

1.00

Others

 Yes

22 (0.04)

3 (0.01)

 Incidence rate per 100,000 person-years (95% CI)

7.62 (4.77 ~ 11.53)

1.04 (0.21 ~ 3.02)

 Adjusted HRa,b (95% CI)

6.75** (2.01 ~ 22.69)

1.00

  1. Notes: aStratified Cox proportional regression stratified on patients’ sex, age group, and index year. b Adjusted for patients’ monthly income, urbanization level, geographic region, hypertension, diabetes, obesity, tobacco use disorder, and alcohol abuse/alcohol dependence syndrome
  2. **p < 0.01, ***p < 0.001